SNTL

 
Common Stock Dark or Defunct
OTC Pink No Information
Contact Info
  • 123 W. Nye Lane, Suite 129
  • Carson City, NV 89706

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status Dark: Alternative Reporting Standard
Audited Financials Unaudited
Latest Report Sep 30, 2016 Quarterly Report
CIK 0001443475
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 9999 - Nonclassifiable establishments
Business Status Development Stage Company a/o
Incorporated In: NV, USA
Year of Inc. 2004
Employees Not Available
Company Officers/Contacts
Mark J Osgood President
Mathew McMurdo General Counsel
Company Directors
Mark Dorey
Company Notes
  • Formerly=Syncronys International, Inc. until 4-2013
  • Formerly=LGM Biopharma, Inc. until 12-07
  • Formerly=China Northwest Biotech Corp. until 6-07
  • Formerly=AVL Global, Inc. until 2-06
Service Providers
Accounting/Auditing Firm
Not Available
Legal Counsel
McMurdo Law Group, LLC
1185 Avenue of the Americas
3rd Floor
New York, NY, 10036
United States

Investor Relations Firm
Not Available
SNTL Security Details
Share Structure
Market Value1 $1,077,782 a/o Oct 19, 2017
Authorized Shares 850,000,000 a/o Jun 30, 2016
Outstanding Shares 673,613,904 a/o Jun 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 230,665,309 a/o Mar 31, 2016
Par Value No Par Value
Transfer Agent(s)
Pacific Stock Transfer Co.
Shareholders
Shareholders of Record 257 a/o Mar 31, 2013
Short Selling Data
Short Interest 0 (-100%)
Feb 29, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security